
Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into a standardized relational database using an AI Data Integration Engine, delivering real-time, clean, and consistent data for actionable insights. The platform includes Rivia Spark, an AI-powered visual intelligence tool that transforms natural language queries into dynamic visualizations and patient-specific insights. Rivia's solutions enhance decision-making across medical and clinical science, safety monitoring, clinical operations, and executive oversight, reducing risks, costs, and accelerating time to market. Trusted by leading innovators like Alentis Therapeutics, Calypso Biotech, and Abcentra Therapeutics, Rivia positions itself as a leader in transforming clinical trial data into insights that drive therapeutic innovation globally.

Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into a standardized relational database using an AI Data Integration Engine, delivering real-time, clean, and consistent data for actionable insights. The platform includes Rivia Spark, an AI-powered visual intelligence tool that transforms natural language queries into dynamic visualizations and patient-specific insights. Rivia's solutions enhance decision-making across medical and clinical science, safety monitoring, clinical operations, and executive oversight, reducing risks, costs, and accelerating time to market. Trusted by leading innovators like Alentis Therapeutics, Calypso Biotech, and Abcentra Therapeutics, Rivia positions itself as a leader in transforming clinical trial data into insights that drive therapeutic innovation globally.
What they do: Unified data and AI analytics platform for clinical trials
Founded: 2022
Headquarters (reported): Canton of Zürich, Switzerland
Recent funding: Seed round announced 2024-06-12
Lead investor (seed): Speedinvest
| Company |
|---|
Clinical trials data fragmentation and slow, inconsistent analytics for biotech and pharmaceutical decision-making
2022
Software Development
€3.0M
Seed round reported by Dealroom and Crunchbase; investors named include Speedinvest, Nina Capital, Amino Collective. Dealroom lists €3.0M for Jun 2024.
“Seed round led by Speedinvest with participation from Nina Capital and Amino Collective”
Company Description
Rivia is a unified data and AI analytics platform specifically designed for biotech clinical trials. The platform integrates fragmented trial data to deliver insights and decisions that drive more predictable operations. By utilizing Rivia, organizations can unlock hidden therapeutic potential and enhance the effectiveness of clinical trials. Rivia is committed to transforming the biotech industry by leveraging data-driven approaches to improve outcomes and efficiency.
Role Description
This is a full-time, on-site Content Strategist role based in Zurich. The Content Strategist will be responsible for developing and managing content strategies to support business objectives and enhance the company’s digital presence. Daily tasks include creating and managing content across various platforms, writing high-quality web content, and collaborating with cross-functional teams to ensure alignment with corporate goals. This role also involves analyzing data to optimize content performance and engagement.
Qualifications
Excellent in
Content Development (articles/papers,
visuals, videos, web pages)
Proven ability to create and execute strategic content plans
Strong analytical skills to measure content performance and impact
Exceptional organizational and collaboration skills
Experience in biotechnology or healthcare industries is a plus
International
experiences